C-low-threshold mechanoreceptors (C-LTMRs) are unique among C-unmyelinated primary sensory neurons. These neurons convey two opposite aspects of touch sensation: a sensation of pleasantness, and a sensation of injury-induced mechanical pain. Here, we show that TAFA4 is a specific marker of C-LTMRs. Genetic labeling in combination with electrophysiological recordings show that TAFA4+ neurons have intrinsic properties of mechano-nociceptors. TAFA4-null mice exhibit enhanced mechanical and chemical hypersensitivity following inflammation and nerve injury as well as increased excitability of spinal cord lamina IIi neurons, which could be reversed by intrathecal or bath application of recombinant TAFA4 protein. In wild-type C57/Bl6 mice, intrathecal administration of TAFA4 strongly reversed carrageenan-induced mechanical hypersensitivity, suggesting a potent analgesic role of TAFA4 in pain relief. Our data provide insights into how C-LTMRderived TAFA4 modulates neuronal excitability and controls the threshold of somatic sensation.
INTRODUCTION
Touch is essential for a myriad of behaviors that range from avoiding harmful stimuli to social bonds. Touch sensation is mediated by a variety of morphologically and physiologically specialized subpopulations of cutaneous afferents known as low-threshold mechanoreceptors (LTMRs). These afferent fibers have their cell bodies clustered in the dorsal root ganglia (DRG) in the trunk and in the trigeminal ganglia (TG) in the head. Their pseudounipolar organization allows protrusion of two distinct axonal branches: one extending to specialized end organs in the periphery, and the other penetrating the spinal cord to synapse with second-order neurons (Li et al., 2011; Lumpkin et al., 2010) . Based on their axon caliber, degree of myelination, speed of action potential (AP) propagation, mechanical threshold, and the rate of adaptation to sustained mechanical stimuli, LTMRs can be split into Ab, Ad, or C fibers (Bessou and Perl, 1969; Li et al., 2011; Smith and Lewin, 2009; Zimmermann et al., 2009) . Although Ab-LTMR afferents are widely accepted to mediate discriminative touch, the functional role of C-LTMR afferents is just emerging. C-LTMR afferents were first identified in the hairy skin of the cat and the monkey (Zotterman, 1939) and later in humans and mice (Bessou et al., 1971; Douglas and Ritchie, 1957; Johansson et al., 1988; Li et al., 2011; Maruhashi et al., 1952; Seal et al., 2009; Zotterman, 1939) . Recent studies have shown that these neurons specifically express tyrosine hydroxylase (TH) and the vesicular glutamate transporter 3 (VGLUT3) and have afferent branches that project to the innermost layer of lamina II of the dorsal horn of the spinal cord and provide rich innervation of trunk and limb hairy skin (Li et al., 2011; Seal et al., 2009 ). C-LTMRs have been proposed to contribute to touch hypersensitivity after injury in mice (Liljencrantz et al., 2013; Seal et al., 2009) and to an affective or emotional component of touch in humans (Lö ken et al., 2009; Olausson et al., 2002) . These data suggest that C-LTMRs have dual functions: a function of pleasantness under normal conditions that can be converted to pain under pathological conditions. Despite recent advances (Nagi et al., 2011; Seal et al., 2009) , the mechanisms controlling this functional duality are poorly understood.
In a recent study, we have identified several genes defining discrete subsets of small diameter nonpeptidergic nociceptors (Legha et al., 2010) . Here, we demonstrate that TAFA4, a chemokine-like secreted protein (Tom Tang et al., 2004) , is specifically expressed in C-LTMRs. Whole-cell recording of fluorescently labeled TAFA4-expressing neurons confirmed that this subset of neurons displays many properties of C-unmyelinated mechano-nociceptors. TAFA4-null mice are viable and respond normally to a variety of acute thermal and mechanical somatic sensations but developed sustained mechanical and chemical hypersensitivity following tissue injury, both of which could be reversed by intrathecally (IT) applied human recombinant TAFA4 protein. In wild-type (WT) C57/Bl6 mice, IT administration of TAFA4 also reversed tissue injury mechanical hypersensitivity. In agreement with increased injury-induced hypersensitivity in TAFA4-null mice, we found significant hyperexcitability of inner lamina II neurons in TAFA4-null mice. Thus, under pathological conditions, C-LTMR-derived TAFA4 modulates the threshold of activation of second-order spinal cord neurons, providing insights into the role of C-LTMRs in response to painful stimuli.
RESULTS

TAFA4 Is a Specific Marker of C-LTMRs
In a previous study, we identified several genes expressed in discrete subsets of DRG neurons (Legha et al., 2010; Moqrich et al., 2004) . Among them, Tafa4 drew specific attention because (1) its transcripts were highly enriched in adult DRG and trigeminal neurons, (2) it marks a small subpopulation of neurons, and (3) it encodes a 100 amino acid-secreted proteins of unknown function that belong to a family of proteins composed of five highly homologous members named the ''TAFA family'' (Tom Tang et al., 2004) .
Using in situ hybridization, we found Tafa4 expressed in approximately 8% and 19% of total lumbar (L4) and thoracic (T12) adult DRG neurons, respectively ( Figure 1A ). Double-fluorescent labeling experiments showed that Tafa4 is completely excluded from TrkA + neurons and identified a subset of Ret + neurons ( Figures 1C and 1D ). TAFA4 + neurons do not bind IB4 and are completely distinct from mrgprd + neurons (Figures 1E and 1F) . In contrast, TAFA4 is predominantly coexpressed with TH and VGLUT3 (Figures 1G and 1H ) and totally excluded from the newly described massage-like-activated MRGPRB4 + neurons (Vrontou et al., 2013) (data not shown). Using VGLUT3-EGFP DRG sections, we found that 92% ± 4% of TAFA4 + neurons coexpress EGFP, and 94% ± 6% of EGFP + neurons coexpress TAFA4 ( Figure 1H ), identifying TAFA4 as a specific marker of C-LTMRs. In contrast to TH and VGLUT3, TAFA4 is almost restricted to DRG and trigeminal neurons with a low expression in CNS neurons, namely in the habenula and in scattered populations of neurons in the nuclei of the brain stem and hypothalamus (data not shown).
TAFA4-Expressing Neurons Display Properties of Mechano-Nociceptors
To investigate the role of TAFA4 in C-LTMRs, we have generated a knockin (KI) mouse model that allows us to genetically label TAFA4-expressing neurons while eliminating TAFA4 protein ( Figure S1A ). GFP + neurons of heterozygous mice projected to the innermost layer of lamina II centrally and exclusively innervated the hairy part of the skin peripherally (Figures S1G-S1J).
Using patch-clamp recordings and calcium imaging, we found that GFP + neurons displayed many properties of C-unmyelinated nociceptors, including small cell capacitance, high input resistance, short-duration AP devoid of prominent hump in the repolarizing phase, and a remarkable concomitant expression of TTX-resistant Nav1.8, low-threshold T-type Ca 2+ (ICa T ), A-type K + current (IK A ), and hyperpolarization-activated h (I h ) currents ( Figures S2A-S2C ). ICa T -mediated rebound potentials were also typically observed at repolarization ( Figure S2D ). The activation of IK A resulted in a delay in the occurrence of APs or rebound potentials in response to positive or negative current steps, respectively ( Figure S2D ). The homogeneous presence of these different currents shapes the cell firing in a unique way, with a depolarizing ''sag'' response to negative current steps due to I h and a ''gap'' in AP firing in response to depolarizing current steps. These firing properties can be used as specific criteria to classify TAFA4-expressing neurons.
GFP + neurons did not respond to many putative nociceptive agents, including capsaicin, menthol, pregnenolone sulfate, and 5HT or to rapid cooling ( Figure S2E ). In contrast, GFP + neurons displayed differential responses to the TRPA1 agonist allyl isothiocyanate (AITC) and to hypoosmotic solution ( Figure S2E ; data not shown), suggesting some functional heterogeneity within C-LTMRs.
Classical features of C-LTMRs, including slow conduction velocities, trains of spikes in response to a light mechanical force, and slow adaptation to a sustained mechanical stimulus, have been determined using ex vivo skin nerve preparations (Bessou et al., 1971; Li et al., 2011; Seal et al., 2009; Woodbury et al., 2001) . Application of mechanical forces to the cell body of GFP + neurons revealed the presence of mechanically activated (MA) cation currents in 95% of neurons tested (Figures 2A and  2B ). Although rapidly adapting MA currents could be occasionally encountered (15%), slow and ultraslowly adapting MA currents were predominant (21.3% and 57.9%, respectively) in GFP + neurons (Figure 2A ). All these currents were cationic and nonselective, with reversal potential ranging from À2 to +4 mV (data not shown). Consistent with the slow adaptation properties of MA currents, slow velocity ramp stimulus was able to trigger APs ( Figure 2B ), indicating that mechanosensory GFP + neurons respond to slow motion stimuli. Taken together, our expression data, combined with calcium imaging and electrophysiological recordings, demonstrate that TAFA4 + neurons display physiological properties of C-unmyelinated mechano-nociceptors.
TAFA4 Is Dispensable for Molecular, Anatomical, and Physiological Properties of C-LTMRs
We first confirmed that TAFA4 transcripts were completely abolished in TAFA4 GFP/GFP homozygous mice (hereafter TAFA4-null mice) (Figures S1B and S1C). Using SCG10 as a pan-neuronal marker, we found no difference in the total number of neurons between TAFA4-null and WT DRGs either at thoracic or lumbar levels ( Figure S1D ). Consistent with these results, quantification of Ret-, TH-, TrkA-, TrkB-, and TrkC-expressing neurons showed no difference between the two genotypes (Figures S1E and S1F), suggesting that these neurons survived, developed, and matured normally in the absence of TAFA4. Furthermore, homozygous GFP + neurons invaded the innermost layer of laminae II centrally and connected with hair follicles peripherally, revealing that the lack of TAFA4 had no effect on central or peripheral axonal extension in vivo (Figures S1I-S1J 0 ).
To determine whether TAFA4 modulates neuronal excitability of C-LTMRs, patch-clamp whole-cell recordings were performed on cultured heterozygous and homozygous GFP + neurons. We found no difference in membrane capacitance or cell input resistance ( Figure 2C ). Loss of TAFA4 had no effect on the distribution or the density of the different MA currents ( Figure 2D ), and AP properties of TAFA4-null neurons were undistinguishable from those of TAFA4 GFP/+ (Figures 2E and 2F) . Injection of depolarizing current pulses of increasing amplitudes revealed no significant difference in the tonic discharge properties ( Figure 2G ). Finally, there was no significant difference in the threshold of AP generation, the latency to generate the second AP, and the total number of APs at any given current intensity ( Figures 2H and 2I ). Together, these results suggest that TAFA4 is dispensable for the developmental specification and physiological function of the class of neurons expressing this secreted protein.
TAFA4-Null Mice Develop Severe Injury-Induced Mechanical and Chemical Hypersensitivity
To gain insights into the functional role of TAFA4 in C-LTMRs, we subjected TAFA4-null mice to a large battery of somatosensory tests under acute, inflammatory, and neuropathic pain conditions. TAFA4-null mice appeared normal in terms of body weight, open field ( Figure S3A ), and rotarod ( Figure S3B ) profiles, demonstrating that TAFA4-null mice do not have abnormalities in motor activity or anxiety. We found no difference between WT and TAFA4-null mice in the hot plate ( Figure S3C ), thermotaxis gradient assay ( Figure S3D ), or Hargreaves' test ( Figure S3E ) as well as in the cold plate, the two temperatures' choice, and the dynamic cold and hot plate tests (data not shown). We then tested TAFA4-null mice for the ability to sense mechanical stimuli under inflammatory and neuropathic conditions. In both paradigms, acute mechanical sensation was unaffected in TAFA4-null mice ( Figures 3A-3H ). In the Carrageenan model, TAFA4-null mice exhibited drastically prolonged pain hypersensitivity in response to all tested filaments. Indeed, whereas carrageenan-induced mechanical hypersensitivity started returning to baseline levels at day 3 postinflammation in WT mice, mechanical hypersensitivity persisted up to 21 days in TAFA4-null mice ( Figures 3A-3C ). Very interestingly, 6 days postinflammation, a time at which we have a highly significant difference between WT and TAFA4-null mice, IT injection of 2 mg of recombinant TAFA4 completely reversed mechanical hypersensitivity of TAFA4-null mice to WT levels. Importantly, injection of TAFA5, another member of the TAFA family, had no effect in TAFA4-null mice ( Figure 3D ), highlighting the specificity of Tafa4. We then sought to test whether TAFA4 could trigger the same effects observed in TAFA4-null mice in a WT context. To test this, we used pure C57/Bl6 mice. As shown in Figure 3E , 6 hr postinflammation, IT administration of TAFA4 but not of TAFA5 reversed carrageenan-induced mechanical hypersensitivity to baseline levels. At day 1 postinflammation (18 hr after TAFA4 administration), TAFA4 effect totally disappeared because mechanical threshold returned back to the level before TAFA4 IT injection. Interestingly, IT administration of TAFA4 did not affect the baseline threshold response of naive mice ( Figure S3G ). Finally, to assess the role of TAFA4 in neuropathic pain, we used the chronic constriction of the sciatic nerve (CCI) model ( Figures 3F-3H ). In this paradigm, TAFA4-null mice also exhibited a prolonged mechanical hypersensitivity phenotype for all tested filaments, and IT administration of recombinant TAFA4, 30 days after CCI, totally reversed CCI-induced mechanical hypersensitivity in TAFA4-null mice to WT levels ( Figures 3F-3H ).
To test whether the enhanced mechanical hypersensitivity in TAFA4-null mice was modality specific, we carried out the formalin test ( Figures 3I and 3J ). Intraplantar injection of 10 ml of 2% formalin triggered a robust first pain response in both genotypes. TAFA4-null mice exhibited a dramatically elevated response in the second phase, suggestive of an enhanced central sensitization in these mice. Importantly, formalin-induced hypersensitivity in TAFA4-null mice was reversed to WT levels after IT administration of TAFA4 15 min before formalin treatment (Figure 3K) . Taken together, our results demonstrate that TAFA4 is required to maintain the normal threshold of injury-induced mechanical and chemical pain hypersensitivity and strongly support a potential role of TAFA4 as a potent analgesic in the settings of inflammation and neuropathy.
Lamina IIi Neurons Exhibit Increased Excitability in TAFA4-Null Mice
To further explore the central sensitization phenotype induced by the loss of TAFA4, we performed whole-cell recordings of lamina IIi neurons in dorsal root-attached spinal cord slices from WT (n = 19) and TAFA4-null mice (n = 25). We found no difference in average membrane potential, cell input resistance, membrane capacitance, or rheobase ( Figures S4A1-S4A4 ). However, injection of depolarizing current pulses of increasing amplitudes (0-50 pA) elicited more APs in TAFA4-null neurons than in WT ( Figures 4A1 and 4A2 ; ANCOVA, p < 0.001). This effect was even more pronounced at the onset of the depolarizing current pulse because TAFA4-null neurons showed increased discharge frequency at the beginning of the current pulse, before adapting to discharge rates comparable with those of WT neurons ( Figure 4A3 ). Furthermore, injection of hyperpolarizing current pulses (À50 or À25 pA) elicited higher rebound AP in TAFA4-null neurons compared to WT ( Figures  4A1 and 4A4 ; p = 0.049 and p = 0.001, respectively). Together, these data suggest an increased excitability of lamina IIi neurons in TAFA4-null mice.
The differences observed in TAFA4-null mice suggest a differential regulation of slowly inactivating low-threshold currents. To characterize these currents, we measured the outward current elicited at À40 mV in lamina IIi neurons using a symmetrical voltage ramp protocol (À40 to À120 mV and back to À40 mV). Whereas in WT neurons, an outward current with slow desensitization could be observed at the end of the rising voltage ramp; this current was almost absent in TAFA4-null neurons ( Figures  4B1 and 4B2 ; p = 0.001). Because IT-administered recombinant TAFA4 diminishes the exaggerated pain behavior in injured TAFA4-null mice, we examined the effects of adding recombinant human TAFA4 on lamina IIi neurons from TAFA4-null mice. We found that exogenous application of TAFA4 (20-30 min, 20 nM) induced the expression of an outward current, similar to that observed in neurons from WT animals in control conditions (i.e., without TAFA4) ( Figures 4C1 and 4C2 , n = 19; p < 0.001). This current was not affected by external TEA (2.5 mM, n = 3) but was completely blocked by 4AP (1 mM), suggesting A-type current pharmacology. These effects were specific to TAFA4 because addition of recombinant TAFA5 (n = 5, Figures 4D1 and 4D2) or TAFA2 (n = 6, Figure 4D2 ) could not elicit this low-threshold outward current from TAFA4-null neurons.
Following TAFA4 addition, the distribution of outward current intensities among lamina IIi neurons was best fitted by a mix of two Gaussian curves, revealing the existence of two distinct populations: one-third of the neurons displayed significant outward currents, whereas the remaining neurons were weakly or not affected by TAFA4 bath application ( Figure 4E1 ). Phenotypic characterization of TAFA4-responsive neurons showed that TAFA4 elicited similar outward currents both in GAD + and GAD À neurons ( Figure 4E2) .
Among low-threshold currents, Ih and T-type calcium currents may also shape the firing of lamina IIi neurons. To characterize Ih-like currents in WT and TAFA4-null mice, we quantified the hyperpolarization-evoked sag by measuring the difference between peak and steady-state potentials in response to a hyperpolarizing current pulse ( Figure S4B1 ). In both genotypes, we found no difference in the distribution of individual points or the quantification of the sag evoked by À50 and À25 pA current pulses ( Figures S4B2 and S4B3) . In contrast, isolated T-type currents evoked by square potential pulses (see Experimental Procedures) were frequently weaker in WT than in TAFA4-null mice ( Figure S4C1 ). Statistical analysis revealed a significant increase in T-type current densities in TAFA4-null lamina IIi neurons compared to WT ( Figure S4C2 ; p = 0.001). However, addition of human recombinant TAFA4 did not alter the T-type current density lamina IIi neurons of TAFA4-null animals ( Figures  S4C3 and S4C4 ), suggesting that the differences in T-type currents observed between WT and TAFA4-null mice may result from compensatory mechanisms rather than from direct action of TAFA4 on lamina IIi neurons. Taken together, our results indicate that TAFA4 directly modulates the intensity of low-threshold outward currents in lamina IIi neurons.
DISCUSSION
In this study, we have used a combination of genetic labeling, electrophysiological recording, and behavioral analyses to unravel the functional role of TAFA4 in C-LTMRs. We showed that TAFA4 + neurons display many intrinsic physiological properties of mechano-nociceptors. We also showed that TAFA4 loss of function led to increased injury-induced mechanical and chemical hypersensitivity and enhanced excitability of laminae IIi neurons. Recombinant TAFA4 is able to reverse injury-induced mechanical and chemical hypersensitivity in a loss of function as well as in a pure WT background. Therefore, TAFA4 plays an important role in modulating neuronal excitability and the threshold of somatic sensation.
Although discovered many decades ago (Zotterman, 1939) , and despite the intense studies regarding their physiological properties, our knowledge of the molecular content, the anatomical organization, and the functional specialization of C-LTMRs is just emerging. Recent studies have shown that C-LTMRs represent a unique population of nonpeptidergic, small diameter sensory neurons that express VGLUT3 and TH (Li et al., 2011; Seal et al., 2009 ). These neurons project to the innermost layer of lamina II in the spinal cord (Seal et al., 2009 ), a layer that has been shown to contribute to persistent pain caused by injury (Malmberg et al., 1997) , and display an exquisite peripheral and central organization with physiologically distinct subtypes of Ab and Ad LTMRs (Li et al., 2011) . Our genetic labeling of TAFA4 + neurons confirmed both findings showing that TAFA4 + afferents exclusively (B) Velocity-related firing property of a TAFA4 GFP/+ neuron is shown. Note that firing was enhanced as mechanical stimuli were applied with slow rates of onset (n = 7). (C) Histograms compare the membrane capacitance (Cm) and the input resistance (Rinput) of TAFA4 GFP/+ (n = 46) and TAFA4-null (n = 37) GFP + DRG neurons. Bars represent mean ± SEM. ns, not significant. (D) Frequency distribution and density of rapidly adapting, slowly adapting, ultraslowly adapting, and mixed MA currents in TAFA4 GFP/+ (n = 33) and TAFA4-null (n = 36) GFP + neurons are shown. (E) Representative AP is evoked by a short depolarizing current injection in a TAFA4-null DRG neuron. (F) Comparison of AP parameters in TAFA4 GFP/+ (n = 16) and TAFA4-null (n = 15) neurons as determined in (C) is shown. (G) Representative recordings of firing discharges evoked in TAFA4 GFP/+ and TAFA4-null GFP + neurons by 500 ms depolarizing current injections are presented. (H) Comparison of the rheobase current (i.e., minimal electric current of 500 ms duration necessary to produce a spike) and first-spike latency in TAFA4 GFP/+ (n = 15) and TAFA4-null (n = 13) GFP + neurons is shown. Data are determined as in (E). (I) Stimulus-frequency relationships in TAFA4 GFP/+ (n = 7) and TAFA4-null (n = 7) neurons using 500 ms depolarizing current injections are presented. See also Figure S2. innervate hair follicles in the periphery and project to the innermost layer of lamina II centrally.
Human psychophysical studies have implicated C-LTMRs in two distinct features of mechanical sensation: sensation of pleasant touch, and sensation of vibration-evoked pain (Lö ken et al., 2009; Nagi et al., 2011) . In the mouse, VGLUT3 loss of function specifically impairs mechanical hypersensitivity following inflammation, nerve injury, and trauma, indicating a critical role of C-LTMRs in the mechanical hypersensitivity caused by injury (Seal et al., 2009) . Our behavioral experiments showed that TAFA4-null mice developed sustained mechanical allodynia and hyperalgesia in the settings of inflammation and nerve injury, suggesting opposite roles of glutamate and TAFA4 in modulating injury-induced mechanical hypersensitivity. It is tempting to postulate that upon activation, C-LTMRs would release both glutamate and TAFA4, with glutamate promoting mechanical hypersensitivity, whereas TAFA4 mainly preventing mechanical hypersensitivity.
The role of VGLUT3 in controlling mechanical hypersensitivity has been recently challenged by a work from Lou et al. (2013) in which RUNX1 has been selectively ablated in C-LTMRs. In these mice, injury-induced mechanical hypersensitivity was similar to control mice even though VGLUT3 expression was drastically impaired, suggesting that VGLUT3 is dispensable for modulating injury-induced mechanical pain. Our study shows that loss of TAFA4 in C-LTMRs leads to enhanced mechanical hypersensitivity in the settings of inflammation and nerve injury, suggesting that C-LTMR activation plays an important role in controlling the thresholds of somatic sensation. How can one reconcile the discrepancies between these different studies? First, it is well established that RUNX1 is required for the maintenance of the expression of a large cohort of genes in RUNX1persistent neurons (Chen et al., 2006) . Thus, ablation of RUNX1 in C-LTMRs might trigger downregulation of a variety of genes whose expression is required for proper function of C-LTMRs, including TAFA4. Dual downregulation of VGLUT3 and TAFA4, which play antagonistic roles, could perfectly explain the phenotype observed in the study by Lou et al. (2013) . Second, because of the broad expression of VGLUT3 in the central and peripheral nervous system, conditional inactivation of VGLUT3 specifically in C-LTMRs will allow accurate genetic dissection of the sensory versus central role of VGLUT3 in injury-induced mechanical pain. Regardless, our study in addition to few other studies (Li et al., 2011; Lou et al., 2013; Seal et al., 2009 ) provide molecular insights into the development, the exquisite topographic central and peripheral organization, and the functional role of C-LTMRs in mechanosensation in vivo.
We also found that TAFA4 modulates the second phase of formalin-evoked pain. However, the neuronal subpopulations and the molecular mechanisms underlying the nocifensive behavior triggered by formalin are still unknown. Recent genetic and chemical neuronal ablation studies suggest that formalinevoked nocifensive behavior is likely to be triggered by a yet to be identified small subset of DRG neurons (Abrahamsen et al., 2008; Cavanaugh et al., 2009; Shields et al., 2010) . Indeed, ablation of a subpopulation of neurons encompassing MRGPRD + and TAFA4 + neuronal subsets significantly reduced the first formalin-evoked pain and completely abolished the second pain response (data not shown). These data, in addition to our observed enhanced formalin-evoked second pain response in TAFA4-null mice, strongly suggest that C-LTMRs are likely to play a role in modulation of formalin-induced pain.
Genetic marking of Tafa4-expressing neurons allowed detailed in vitro study of the physiological properties of C-LTMRs. Patch-clamp analysis revealed a strikingly homogeneous population of neurons with small capacitance, unique short-duration APs, Nav1.8 currents, and a remarkable coexpression of several low-threshold currents as well as slowly and ultraslowly adapting excitatory mechano-gated currents. Loss of TAFA4 does not seem to interfere with the excitability of C-LTMRs, potentially indicating the absence of a cell-autonomous role of this secreted protein in this process. However, it remains possible that the lack of significant differences observed in this study might be due to the fact that our experiments compare heterozygous with homozygous GFP + neurons. Indeed, although not significant, Figure 2I shows a tendency of homozygous GFP + neurons to exhibit less APs compared to heterozygous GFP + neurons.
Sensory inputs from the periphery are processed and conveyed to higher brain regions by complex circuits involving excitatory and inhibitory interneurons within the spinal cord Todd, 2010) . The balance between excitation and inhibition is crucial for the maintenance of normal sensory function, and dysfunction of these circuits leads to the development of inflammatory and neuropathic pain. Our Figure 3 . Tissue-Injury-Induced Hypersensitivity Is Increased in TAFA4-Null Mice (A-C) Time course shows mechanical sensitivity of TAFA4-null mice (n = 12) and WT littermates (n = 7) before (Day 0) and following Carrageenan injection using three different filaments of increasing calibers (0.07, 0.6, and 1.4 g). (D) Time couse presents mechanical sensitivity of WT and TAFA4-null littermates (n = 6) before and after Carrageenan injection using an ''up and down method''. At day 6 and day 7, the mechanical threshold was measured before and 15 min after IT injection of 2 mg of human recombinant TAFA4 or TAFA5, respectively.
(E) Time course shows mechanical sensitivity of C57Bl6 mice before and following Carrageenan injection. Recombinant TAFA4 (n = 8) and TAFA5 (n = 7) were administered at 6 hr postinflammation. (F-H) Time course presents mechanical sensitivity following CCI of TAFA4-null mice (n = 12) and WT littermates (n = 13) using three different filaments of increasing calibers (0.07, 0.6, and 1.4 g). Measures were determined before (Day 0) and every 5 days after the CCI. At Day +30, the score is before and 15 min after IT injection of 2 mg of human recombinant TAFA4 (TAFA4-null mice [n = 5], WT [n = 7]). (I and J) Time course and total time (in two phases: first 0-10 min and second 10-60 min) spent in flinching, biting, and licking behavior following 2% formalin injection (WT n = 11 and TAFA4-null mice n = 12) are shown. (K) IT injection of 2 mg of human recombinant TAFA4 restores formalin-evoked hypersensitivity to WT levels in TAFA4-null mice (vehicle n = 8, TAFA4 n = 8). Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001, one-way ANOVA followed by unpaired t test. See also Figure S3 . (A3) Average firing rate at different times of the discharge elicited by a 2 s depolarizing current pulse (+25 pA) in lamina IIi neurons of WT and TAFA4-null mice is presented. (A4) Average number of rebound APs following a 2 s hyperpolarizing current pulse (À50 and À25 pA) (t test, p < 0.05) is shown.
(B1) Representative current responses from WT and TAFA4-null neurons to a back-and-forth voltage ramp from À40 to À100 mV are shown. Each trace represents the average of five consecutive responses. (B2) Quantification of the peak of the outward current measured at the end of the rising voltage ramp in lamina IIi neurons of WT and TAFA4-null animals (t test, p < 0.05) is presented. (C1) Response of a TAFA4-null lamina IIi neuron to a back-and-forth voltage ramp in control conditions and in the presence of 20 nM recombinant TAFA4, TEA (2.5 mM), and 4AP (1 mM), is shown. (C2) Quantification of the outward current measured at the end of the rising edge of the voltage ramp in TAFA4-Lamina IIi neurons is shown. Notice the increase in outward current following TAFA4 application (p < 0.05), and the blockade of this current by 4AP. (D1 and D2) Representative traces and quantification of the outward current in lamina IIi neurons of TAFA4-null animals following the bath super fusion of TAFA5 and TAFA2 (20 nM each) are shown. (E1) Occurrence of low-threshold outward current in WT and following recombinant TAFA4 superfusion is presented. (E2) Examples of lamina GAD65 À /GAD67 À (left) and GAD65 + /GAD67 + (right) neurons are shown. Images are single confocal planes. White arrows indicate the labeling of GAD + soma. See also Figure S4 . study shows that the loss of TAFA4 led to enhanced excitability of lamina IIi neurons. Intriguingly, we found no significant differences in ion channel conductances in the cell soma of cultured TAFA4-null GFP + neurons compared to TAFA4 GFP/+ neurons. Nonetheless, it is conceivable that TAFA4 could acutely regulate presynaptic channels in primary afferents that in turn increase synaptic transmission. Postsynaptically, the ''TAFA4ergic'' C-LTMR afferents face a network of lamina IIi excitatory glutamatergic and inhibitory GABAergic/glycinergic interneurons that are connected to projection neurons residing in lamina I. Although this wiring is not fully understood, we propose an attractive hypothesis in which, in a WT situation, under pathological conditions, elevated neuronal activity in C-LTMRs would enhance tonic secretion of TAFA4 that will depress a subset of glutamatergic excitatory and GABAergic inhibitory interneurons, through the activation of a low-threshold outward current. Because excitatory transmission dominates sensory processing in substantia gelatinosa (Santos et al., 2007) , the net result of this dual depression of GAD + and GAD À cells would be dominated by a decrease in excitatory transmission, thereby reducing the amount of nociceptive information transmitted to lamina I projection neurons. TAFA4 effect on excitatory and inhibitory interneurons is not surprising but rather consistent with previous studies showing other mediators, with strong antinociceptive effects, altering inhibitory and excitatory spinal interneurons (Yasaka et al., 2010) . Further work aimed at deciphering the molecular machinery that triggers injury-induced release of TAFA4 in addition to identification of the receptors through which TAFA4 exerts its modulatory action on spinal cord interneurons will greatly advance our understanding of the role of C-LTMR-derived TAFA4 in pain processing.
EXPERIMENTAL PROCEDURES
Generation of tafa4-GFP KI Mice To generate tafa4-GFP KI mice, we used the bacterial artificial chromosome (BAC)-based homologous recombination in embryonic stem cells. Details are available in Supplemental Experimental Procedures.
In Situ Hybridization and Immunofluorescence
In situ hybridization and immunofluorescence were performed following standard protocols (Moqrich et al., 2004) . RNA probes (Tafa4, TH, Vglut3, TrkB, MrgprD, and SCG10) were synthesized using gene-specific PCR primers and cDNA templates from embryonic or adult mouse DRG. Primary antibodies, neuronal counts, and statistical analyses are described in Supplemental Experimental Procedures.
Electrophysiological Recording and Calcium Imaging
Whole-cell patch-clamp recordings of cultures of DRG neurons and from spinal cord slices with attached dorsal root as well as calcium-imaging protocols are described in Supplemental Experimental Procedures. 
Behavioral Assays
